Green Cross Corporation
79
1
1
54
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
6.3%
5 terminated/withdrawn out of 79 trials
91.5%
+5.0% vs industry average
39%
31 trials in Phase 3/4
6%
3 of 54 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (79)
Safety Study of MGAH22 in HER2-positive Carcinomas
Role: collaborator
A Study of GC1111 in Hunter Syndrom Patients
Role: lead
Evaluate the Safety and Immunogenicity After MG1111(BARICELA Inj.) as 2nd Vaccination in 4 ~ 6 Year Old Healthy Children With a History of 1st Varicella Vaccination
Role: lead
A Study to Assess Dose-Response, Efficacy (Immunogenicity) and the Safety of GC1109
Role: lead
Study of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency
Role: lead
A Study of GC3107(BCG Vaccine) in Healthy Infants
Role: lead
A Study to Assess Safety, Efficacy, Immunogenicity, PK of GC1118 With Combination Chemotherapy
Role: lead
A Study to Investigate the Safety, Tolerability, PK and PD of MG1113 in Healthy Subjects and Hemophilia Patients
Role: lead
COVIDIG (COVID-19 Hyper-ImmunoGlobulin)
Role: lead
A Study of MG1111 in Healthy Children
Role: lead
Safety, Tolerability, and Immunogenicity of CRV-101 in Healthy Adult Subjects
Role: collaborator
A Multicenter Prospective Phase II Study of Modified FOLFIRINOX for 1st Line Treatment for Advanced Urachus Cancer
Role: collaborator
Study of Immune Globulin Intravenous (Human) GC5101F in Subjects With Primary Humoral Immunodeficiency
Role: lead
Safety and Efficacy of IGIV 10% in Patients With Autoimmune Encephalitis:
Role: lead
Study of Combined Therapy IVIG-SN 10% and Acetylsalicylic Acid in Kawasaki Disease
Role: lead
HBV-associated Liver Transplant(LT) Patients by IV Injecting GC1102
Role: lead
A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3111 in Healthy Adults
Role: lead
A Study of GC1102(Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B Patients
Role: lead
Influenza Vaccination in Patients Receiving Immune Checkpoint Inhibitor
Role: collaborator
Compare Sequential and Quadruple Therapy for the Eradication of Helicobacter Pylori in Korea
Role: collaborator